Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel hears expanded medical cannabis bill that would raise THC cap and allow inhalable delivery
Summary
A Georgia Senate committee heard extended testimony on Senate Bill 220, a proposal to rename the state's low-THC program, raise the THC cap to 50 percent, allow inhalable (vaped) delivery, and broaden qualifying conditions; committee deferred final action for further work.
Senate Bill 220, a proposal to change Georgia's low-THC oil program into a broader "medical cannabis" framework and to raise the allowable THC potency from 5 percent to 50 percent, drew extended testimony and debate before the committee but received no final vote.
Proponents said the changes are intended to improve clinical options for patients and to bring Georgia more in line with other medical-only states. "We're asking ... to allow the folks that qualify in this state to have the right amount that helps their disease," former state representative Micah Gravely told the committee, recounting patients who had benefited in other states. Attorney Edward Lindsey, representing an industry license holder, summarized technical changes, saying the bill "changes the term in section 2 ... from low THC oil ... to medical cannabis" and noted the proposal would raise the program's potency cap and alter possession limits.
Supporters said the measure also would permit an…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
